CAMBRIDGE, United Kingdom, April 08, 2024 (GLOBE NEWSWIRE) -- Mestag Therapeutics (Mestag), a biotech company harnessing new insights into fibroblast-immune interactions, is today presenting data...
Mestag Therapeutics M300 Program Selected for Poster Presentation
CAMBRIDGE, United Kingdom, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Mestag Therapeutics (Mestag), a biotech company harnessing new insights into fibroblast-immune interactions to develop impactful...
CAMBRIDGE, United Kingdom, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Mestag Therapeutics (œMestag), a biotech company harnessing new insights into fibroblast-immune interactions to develop impactful...